NKGen Biotech secures $2.42M additional convertible funding from AlpineBrook
NKGen Biotech amended its secured convertible loan agreement to receive $2.42 million in additional funding from AlpineBrook Capital, with new warrant issuance. The financing extension demonstrates continued investor support for the biotech company's capital needs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day